Organ Transplantation
29
4
5
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 29 trials
100.0%
+13.5% vs benchmark
10%
3 trials in Phase 3/4
14%
2 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (29)
The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Organ Transplant Patients
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)
Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients
Leuven Tolerogenic Protocol for Intestinal Transplantation
Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management
Immunosuppressants to Postoperative Infection and Death
Immune Monitoring and Assay Development in Organ Transplant Recipients
The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT)
Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation
The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation
Reducing the Burden of Influenza After Solid-Organ Transplantation
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Belatacept Post Depletional Repopulation to Facilitate Tolerance
A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation
Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Remote Ischemic Preconditioning in Neurological Death Organ Donors